GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Precipio Inc (FRA:TGK) » Definitions » Cash And Cash Equivalents

Precipio (FRA:TGK) Cash And Cash Equivalents : €0.71 Mil (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Precipio Cash And Cash Equivalents?

Precipio's quarterly cash and cash equivalents declined from Sep. 2023 (€1.46 Mil) to Dec. 2023 (€1.38 Mil) but then stayed the same from Dec. 2023 (€1.38 Mil) to Mar. 2024 (€0.71 Mil).

Precipio's annual cash and cash equivalents declined from Dec. 2021 (€10.33 Mil) to Dec. 2022 (€3.25 Mil) and declined from Dec. 2022 (€3.25 Mil) to Dec. 2023 (€1.38 Mil).


Precipio Cash And Cash Equivalents Historical Data

The historical data trend for Precipio's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Precipio Cash And Cash Equivalents Chart

Precipio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 2.18 10.33 3.25 1.38

Precipio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.38 1.46 1.38 0.71

Precipio Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Precipio  (FRA:TGK) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Precipio Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Precipio's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Precipio (FRA:TGK) Business Description

Traded in Other Exchanges
Address
4 Science Park, New Haven, CT, USA, 06511
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings.

Precipio (FRA:TGK) Headlines

No Headlines